SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $368,579 | -54.1% | 13,364 | -50.4% | 0.00% | -100.0% |
| Q2 2023 | $803,472 | +7.1% | 26,917 | +31.2% | 0.00% | 0.0% |
| Q1 2023 | $750,534 | -22.8% | 20,512 | -24.9% | 0.00% | 0.0% |
| Q4 2022 | $972,670 | +23.0% | 27,330 | +17.8% | 0.00% | 0.0% |
| Q3 2022 | $791,000 | +54.5% | 23,196 | +29.9% | 0.00% | 0.0% |
| Q2 2022 | $512,000 | -6.9% | 17,852 | +5.1% | 0.00% | 0.0% |
| Q1 2022 | $550,000 | +128.2% | 16,991 | +119.0% | 0.00% | – |
| Q2 2021 | $241,000 | -24.2% | 7,758 | -48.7% | 0.00% | -100.0% |
| Q3 2020 | $318,000 | -86.5% | 15,111 | -70.7% | 0.00% | -75.0% |
| Q1 2018 | $2,363,000 | +1058.3% | 51,590 | +538.4% | 0.00% | – |
| Q4 2016 | $204,000 | – | 8,081 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |